Speech and language therapy for Parkinson’s disease. Clare Herd Research Associate.

Slides:



Advertisements
Similar presentations
Protocol Development.
Advertisements

Introducing... Reproduced and modified from a presentation produced by Zoë Debenham from the original presentation created by Kate Light, Cochrane Trainer.
Student Learning Development, TCD1 Systematic Approaches to Literature Reviewing Dr Tamara O’Connor Student Learning Development Trinity College Dublin.
Systematic Approaches to Literature Reviewing
Systematic review of the ‘added value’ for well-being of physical activity in outdoor natural environments Ruth Garside Senior Lecturer in Evidence Synthesis.
St John’s wort for major depression (Review) Linde, Berner & Kriston (2008/9)
Accessing Sources Of Evidence For Practice Introduction To Databases Karen Smith Department of Health Sciences University of York.
Aphasia – Treatment effectiveness and evidence based practice.
Meta-Analysis: Low-dose dopamine Increases urine output but does not prevent renal dysfunction or death Annals of Internal Medicine 2005; 142:
Gut-directed hypnotherapy for functional abdominal pain or irritable bowel syndrome in children: a systematic review Journal club presentation
E. McLaughlin, P. D. Chakravarty, D. Whittaker, E. Cowan, K. Xu, E. Byrne, D.M. Bruce, J. A. Ford University of Aberdeen.
Developing Research Proposal Systematic Review Mohammed TA, Omar Ph.D. PT Rehabilitation Health Science.
Their contribution to knowledge Morag Heirs. Research Fellow Centre for Reviews and Dissemination University of York PhD student (NIHR funded) Health.
Treatment for Adolescents With Depression Study (TADS)
SYSTEMATIC REVIEWS AND META-ANALYSIS. Objectives Define systematic review and meta- analysis Know how to access appraise interpret the results of a systematic.
THE COCHRANE LIBRARY ON WILEY INTERSCIENCE. Presentation Agenda Brief introduction of Evidence-Based Medicine theories The Cochrane Collaboration – origins,
Systematic Approaches to Literature Reviewing Dr. Derek Richards derek.richards [at] tcd.ie.
Systematic Reviews.
How to Analyze Systematic Reviews: practical session Akbar Soltani.MD. Tehran University of Medical Sciences (TUMS) Shariati Hospital
Evidence Based Medicine Meta-analysis and systematic reviews Ross Lawrenson.
Introduction to Systematic Reviews Afshin Ostovar Bushehr University of Medical Sciences Bushehr, /9/20151.
A systematic meta-analysis of randomized controlled trials for adjuvant chemotherapy for localized resectable soft-tissue sarcoma Nabeel Pervaiz Nigel.
Should developing countries continue to use older drugs for essential hypertension? A prescription survey in South Africa suggested that prescribers were.
Plymouth Health Community NICE Guidance Implementation Group Workshop Two: Debriding agents and specialist wound care clinics. Pressure ulcer risk assessment.
Clinical Writing for Interventional Cardiologists.
Assessing effectiveness Montarat Thavorncharoensap, Ph.D. 1: Faculty of Pharmacy, Mahidol University 2. HITAP, Thailand.
RevMan for Registrars Paul Glue, Psychological Medicine What is EBM? What is EBM? Different approaches/tools Different approaches/tools Systematic reviews.
Evidence Based Review. Introduction to Evidence Based Reviews Systematic reviews comprehensively examine the medical literature, –seeking to identify.
2nd Concertation Meeting Brussels, September 8, 2011 Reinhard Prior, Scientific Coordinator, HIM Evidence in telemedicine: a literature review.
Objectives  Identify the key elements of a good randomised controlled study  To clarify the process of meta analysis and developing a systematic review.
Moving the Evidence Review Process Forward Alex R. Kemper, MD, MPH, MS September 22, 2011.
Trusted evidence. Informed decisions. Better health. Cochrane_QuickRefBooklet.indd 114/8/15 5:41 pm.
Sifting through the evidence Sarah Fradsham. Types of Evidence Primary Literature Observational studies Case Report Case Series Case Control Study Cohort.
1 Lecture 10: Meta-analysis of intervention studies Introduction to meta-analysis Selection of studies Abstraction of information Quality scores Methods.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence November-December 2012.
Internet Resources for Evidence-Based Practice Ben Skinner KnowledgeShare.
Systematic reviews and meta-analyses: when and how to do them Andrew Smith Royal Lancaster Infirmary 18 May 2015.
Evidence Based Practice (EBP) Riphah College of Rehabilitation Sciences(RCRS) Riphah International University Islamabad.
Chronic pelvic pain Journal Club 17 th June 2011 Dr Claire Hoxley (GPST1) Dr Harpreet Rayar (GPST2)
1 Lecture 10: Meta-analysis of intervention studies Introduction to meta-analysis Selection of studies Abstraction of information Quality scores Methods.
Selenium supplementation for the primary prevention of cardiovascular disease: a Cochrane review Clinical
Meri Mirčeta, Ana-Maria Mitar Medicinski fakultet, Medicina Sveučilište u Splitu 3.ožujka.2016.
Introduction to Systematic Reviews Afshin Ostovar 6/24/
Systematic Reviews of Evidence Introduction & Applications AEA 2014 Claire Morgan Senior Research Associate, WestEd.
A Summary of a Systematic Review Robert Williams, LCSW, BCD University of Utah.
Contact: Patrick Phillips,
Trial Sequential Analysis (TSA)
Psychosocial Combined with Agonist Maintenance Treatments versus Agonist Maintenance Treatments Alone for Treatment of Opioid Dependence (Review) Amato,
Brady Et Al., "sequential compression device compliance in postoperative obstetrics and gynecology patients", obstetrics and gynecology, vol. 125, no.
Effects of Uric acid- lowering therapy on renal outcomes: a systematic review and meta-analysis Nephrol Dial Transplant (2014) 29: Vaughan Washco.
Institute of Health and Society, Newcastle University
Kris McGill, Jon Godwin, Catherine Sackley, Marian C Brady
Robert West University College London London March 2008
How to read a paper D. Singh-Ranger.
Clinical Study Results Publication
Strategies to incorporate pharmacoeconomics into pharmacotherapy
M.Vooijs, P.Siemonsma, I.Heus, J.Sont, A.Rövekamp, N. van Meeteren
Effective evidence-based occupational therapy
Foroutan N1,2, Muratov S1,2, Levine M1,2
Critical Reading of Clinical Study Results
H676 Meta-Analysis Brian Flay WEEK 1 Fall 2016 Thursdays 4-6:50
Pearls Presentation Use of N-Acetylcysteine For prophylaxis of Radiocontrast Nephrotoxicity.
Systematic Approaches to Literature Reviewing
Introduction to Systematic Reviews
Dr. Maryam Tajvar Department of Health Management and Economics
Tac vs Cyc Non DM Pt Post RTx
Does cinnamon reduce fasting blood glucose in Type II diabetics?
Table of Contents – Part B
Trent Regional SAPC Conference 19 March 2019
Introduction to Systematic Reviews
Presentation transcript:

Speech and language therapy for Parkinson’s disease. Clare Herd Research Associate

Contents ‐The importance of reviewing the literature prior to undertaking new research & the value of systematic reviews ‐The steps involved in conducting a systematic review of available evidence on the topic ‘Speech and language therapy for people with Parkinson’s disease’.

Definitions ‐Review (narrative): all attempts to synthesise the results & conclusions of two or more publications on a given topic ‐Systematic review: when a review strives to comprehensively identify & track down all the literature on a given topic ‐Meta-analysis: an overview incorporating a specific statistical strategy for assembling the results of several studies into a single estimate

Why carry out systematic reviews / meta-analyses Provide totality of the evidence  SRs / MAs: summarise existing evidence base by providing manageable information on which decisions on health policy and individual treatment can be based Assist the practice of evidence-based health care  SRs / MAs minimise bias and present a clearer picture of the current state of evidence  Improve the reliability and accuracy of any recommendations

Objective Update two Cochrane systematic reviews published in 2001 –Speech and language therapy versus placebo or no intervention for Parkinson’s disease –Comparison of speech and language therapy techniques for Parkinson’s disease Deane K et al. Speech and language therapy for dysarthria in Parkinson's disease. Cochrane Database of Systematic Reviews 2001, Issue 2 Deane K et al. A comparison of speech and language therapy techniques for dysarthria in Parkinson's disease. Cochrane Database of Systematic Reviews 2001, Issue 2

Methods Inclusion criteria:  Randomised or quasi randomised controlled trials  SLT vs. placebo or no intervention, and SLT A vs. B  Participants with a diagnosis of PD, any duration of PD, all ages, any duration of treatment. P – People with diagnosis of PD I – SLT C – Placebo/ no intervention/ 2 nd SLT technique O – Speech S – RCT’s

Search strategy The following MeSH and free terms were used combined with RCT study design filter: a. Dysarthria OR speech OR speak OR intelligibility OR dysprosody OR hypophonia OR monotonicity OR phonate b. ((Speech OR speak OR language OR voice OR vocal OR articulate OR sing) near (task OR therapy OR treatment OR train OR counsel OR intervention OR exercise OR drill OR rehabilitation)) OR silverman OR LSVT c. Parkinson OR Parkinson's disease OR Parkinsonism d. (#a AND #b AND #c) OR (#a and #c)

Methods Literature search (to April 2011) for RCTs of SLT interventions using:  Electronic databases (e.g. MEDLINE, EMBASE)  Trials registers (e.g. Cochrane Controlled Trials Register, metaRegister of Controlled Trials, ClinicalTrials.gov)  Conference proceedings  Reference lists

Methods  Data extracted independently by two people, with any discrepancies resolved by consensus or discussion with a third person.  Standard meta-analysis methods for continuous data ‐ Mean difference between arms ‐ Forest plots of change from baseline to end of the treatment period or follow-up.

Outcome measures  Total impairments  Objective and subjective acoustic measures of speech samples  Level of communication participation  Activities of daily living  Handicap and quality of life measures  Depression rating scales  Adverse effects  Carer outcomes  Economic analysis

Methods Search Abstract screening (1054) In/Out (35) Data Extraction (3) Preparation of manuscript Data Extraction (6) Preparation of manuscript SLT vs no interventionSLT A vs B

Speech and language therapy versus placebo or no intervention for speech problems in Parkinson’s disease. Herd C et al. Cochrane Database of Systematic Reviews 2012, Issue 2.

Summary of included trials – SLT vs no intervention Study Number of Patients analysed Mean Age Mean Hoehn & Yahr Score Duration of therapy Type of therapyComparison Johnson n/a 10 hours/4 weeks Prosodic exercises with visual feedback No intervention Ramig hours/4 weeks Phonatory effort (LSVT) No intervention Robertson n/a 40 hours/2 weeks Respiration, loudness, prosody with visual feedback No intervention Total63

Risk of bias summary – SLT vs no intervention

Methodological quality - SLT vs no intervention  Insufficient numbers of participants to avoid reaching false negative conclusions and to reduce the possibility of selection bias.  All three trials failed to clearly define their disease of interest or state their inclusion and exclusion criteria.  Blinding of assessors could not be confirmed for any of the included trials.

Results – SLT vs no intervention  The trials used a variety of treatment methods and outcome measures.  This heterogeneity meant that meta-analysis was possible in only a couple of instances.

Results – SLT vs no intervention SPL of monologue speech / dB

Results – SLT vs no intervention SPL of reading a passage / dB

Results – SLT vs no intervention  The objective loudness of the patients’ speech improved, with all types of speech modality measured, after therapy.  Primary outcome of interest is improved intelligibility, none of the trials reviewed used QOL or intelligibility scales.  Adverse events were not reported by any of the trials included in this review.  Economic analyses were not carried out for any of the studies.

Conclusions - SLT vs no intervention  Improvements in speech impairments were noted in the 41 participants evaluable from these studies, though it cannot be stated whether or not these changes were clinically significant.  Considering the methodological flaws in many of the studies, the small number of patients examined, and the possibility of publication bias, there is insufficient evidence to support or refute the efficacy of speech and language therapy for speech problems in Parkinson's disease.

Herd C et al. Cochrane Database of Systematic Reviews 2012, Issue 2. Comparison of speech and language therapy techniques for speech problems in Parkinson’s disease.

Study Number of Patients analysed Mean Age Mean Hoehn & Yahr Score Duration of therapy Therapy ATherapy B Constantinescu hours/1 month LSVT - online delivery LSVT - face-to- face delivery Halpern n/a 13 hours 20 mins/1 month LSVT ARTIC - enhanced articulation LSVT LOUD - increased loudness Healy n/a 1 hour session or 6 hour long sessions over 6 weeks Alphabet boardPacing board Lowit hours/6 weeks Altered auditory feedback - in ear device Traditional rate reduction therapy Ramig hours/1 month LSVT - increased loudness Respiration therapy Scott n/a 10 hours/2 weeks Prosodic exercises with visual feedback Prosodic exercises alone Total159

Risk of bias summary – SLT A vs B

Results – SLT A vs B  All included trials assessed intelligibility and almost all results were not statistically significant.  All three trials for LSVT recorded loudness measures. Patients showed a greater improvement from LSVT than alternative therapies for this outcome.  Objective measures of monotonicity of a monologue also favoured the LSVT method.

Results – SLT A vs B  Outcome measures from two trials could not be analysed for statistical significance due to missing data.  Constantinescu et al (2011) reported no significant difference between online LSVT and face-to-face delivery in reading and monologue loudness, intelligibility and monotonicity.

 The small number of patients examined, the low methodological quality of the trials evaluated and the possibility of publication bias resulted in an inability to determine the superiority of any one type of SLT over another. Conclusions - SLT A vs B

Implications of results  Further large scale RCTs are needed, with longer follow up periods and should utilise outcome measures that are meaningful to patients.  More evidence to support the efficacy of SLT for speech problems in PD is required before meaningful comparisons between various techniques can be made.

Acknowledgements  Carl Clarke  Claire Smith  Katherine Deane  Christina Smith  Marian Brady  Catherine Sackley  UK Cochrane centre